Abstract:Radiation therapy is prescribed to more than 50% of patients diagnosed with cancer. Although mechanisms of interaction between radiation and tumour cells are well understood on a molecular level, much remains uncertain concerning the interaction of radiation with the tumour as a whole. Recent studies have demonstrated that single large doses of radiation (8–20 Gy) may primarily target tumour endothelial cells, leading to secondary tumour clonogenic cell death. These studies suggest that blood vessels play an important role in radiation response. As a result, various strategies have been proposed to effectively combine radiation with vascular targeting agents. While most proposed schemes focus on methods to disrupt tumour blood vessels, recent evidence supporting that some anti-angiogenic agents may “normalize” tumour blood vessels, in turn enhancing tumour oxygenation and radiosensitivity, indicates that there may be more efficient strategies. Furthermore, vascular targeting agents have recently been demonstrated to enhance radiation therapy by targeting endothelial cells. When combined with radiation, these agents are believed to cause even more localized vascular destruction followed by tumour clonogenic cell death. Taken together, it is now crucial to elucidate the role of tumour blood vessels in radiation therapy response, in order to make use of this knowledge in developing therapeutic strategies that target tumour vasculature above and beyond classic clonogenic tumour cell death. In this report, we review some major developments in understanding the importance of tumour blood vessels during radiation therapy. A discussion of current imaging modalities used for studying vascular response to treatments will also be presented.

Tumor Resistance to Vascular Disrupting Agents: Mechanisms, Imaging, and Solutions.

Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect

Advances In Combination Of Antiangiogenic Agents Targeting Vegf-Binding And Conventional Chemotherapy And Radiation For Cancer Treatment

The Role of Modern Medical Imaging in Evaluation of Tumor Response to Vascular Targeting Therapy

Vascular Strategies for Enhancing Tumour Response to Radiation Therapy

Advances in tumor vascular growth inhibition

Recent advances of nanotechnology-based tumor vessel-targeting strategies

Anti-angiogenic Therapy for Tumor: Tumor Angiogenesis, Vasculogenic Mimicry and Vascular Normalization

Biomaterials-Mediated Tumor Infarction Therapy

Enhanced Antitumor Efficacy of a Vascular Disrupting Agent Combined with an Antiangiogenic in a Rat Liver Tumor Model Evaluated by Multiparametric MRI

Recent advances in, and challenges of, anti-angiogenesis agents for tumor chemotherapy based on vascular normalization

Emerging Biomaterials-Based Strategies for Inhibiting Vasculature Function in Cancer Therapy

Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy

Adaptive resistance of tumor cells to anti-vascular endothelial growth factor therapy: A reversible phenomenon

Targeting the Tumor Vascular Supply to Enhance Radiation Therapy Administered in Single or Clinically Relevant Fractionated Schedules

Progress on angiogenic and antiangiogenic agents in the tumor microenvironment

Tumor angiogenesis: causes, consequences, challenges and opportunities

Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and (19)F MRI

Research progress in tumor angiogenesis and drug resistance in breast cancer

Anti-angiogenic Nano-Delivery System Promotes Tumor Vascular Normalizing and Micro-Environment Reprogramming in Solid Tumor

Recent advances of combretastatin A4-type vascular disrupting agents